Advertisement
UK markets closed

  • FTSE 100

    8,285.71
    +99.36 (+1.21%)
     

  • FTSE 250

    21,356.30
    +471.95 (+2.26%)
     

  • AIM

    779.67
    +6.64 (+0.86%)
     

  • GBP/EUR

    1.1844
    -0.0006 (-0.05%)
     

  • GBP/USD

    1.2873
    +0.0019 (+0.14%)
     

  • Bitcoin GBP

    53,567.08
    +1,362.61 (+2.61%)
     

  • CMC Crypto 200

    1,394.81
    +64.20 (+4.83%)
     

  • S&P 500

    5,459.10
    +59.88 (+1.11%)
     

  • DOW

    40,589.34
    +654.27 (+1.64%)
     

  • CRUDE OIL

    76.44
    -1.84 (-2.35%)
     

  • GOLD FUTURES

    2,385.70
    +32.20 (+1.37%)
     

  • NIKKEI 225

    37,667.41
    -202.10 (-0.53%)
     

  • HANG SENG

    17,021.31
    +16.34 (+0.10%)
     

  • DAX

    18,417.55
    +118.83 (+0.65%)
     

  • CAC 40

    7,517.68
    +90.66 (+1.22%)
     
PROPERTY:

8 champion homes in Olympic host cities

A selection of properties in former Games cities as Paris 2024 starts

EU antitrust regulators set Oct. 19 deadline for Pfizer's Seagen deal

Reuters
·1-min read
Illustration shows test tubes and Seagen logo

BRUSSELS (Reuters) - Pfizer's $43 billion bid for Seagen will be decided by EU antitrust regulators by Oct. 19, a regulatory filing showed on Friday.

U.S. pharmaceutical company Pfizer announced the deal, its biggest, in March for Washington-based Seagen, a pioneer of antibody-drug conjugates, which work like "guided missiles" designed to destroy cancer while sparing healthy cells.

The European Commission can either clear the deal after a preliminary review or it can start a four-month long investigation if it has serious concerns.

Pfizer sought EU antitrust approval on Thursday.

(Reporting by Foo Yun Chee; editing by Grant McCool)